JP2025123368A5 - - Google Patents
Info
- Publication number
- JP2025123368A5 JP2025123368A5 JP2025099242A JP2025099242A JP2025123368A5 JP 2025123368 A5 JP2025123368 A5 JP 2025123368A5 JP 2025099242 A JP2025099242 A JP 2025099242A JP 2025099242 A JP2025099242 A JP 2025099242A JP 2025123368 A5 JP2025123368 A5 JP 2025123368A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/426,124 | 2019-05-30 | ||
| US16/426,124 US12152281B2 (en) | 2019-05-30 | 2019-05-30 | Gene therapy vector contamination assay |
| PCT/US2020/034146 WO2020242913A1 (en) | 2019-05-30 | 2020-05-22 | Ultra-high-precision viral vector assay |
| JP2021569884A JP7755490B2 (ja) | 2019-05-30 | 2020-05-22 | 超高精度ウイルスベクターアッセイ |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569884A Division JP7755490B2 (ja) | 2019-05-30 | 2020-05-22 | 超高精度ウイルスベクターアッセイ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025123368A JP2025123368A (ja) | 2025-08-22 |
| JP2025123368A5 true JP2025123368A5 (enExample) | 2025-11-18 |
Family
ID=67984844
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569884A Active JP7755490B2 (ja) | 2019-05-30 | 2020-05-22 | 超高精度ウイルスベクターアッセイ |
| JP2025099242A Pending JP2025123368A (ja) | 2019-05-30 | 2025-06-13 | 超高精度ウイルスベクターアッセイ |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569884A Active JP7755490B2 (ja) | 2019-05-30 | 2020-05-22 | 超高精度ウイルスベクターアッセイ |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12152281B2 (enExample) |
| EP (1) | EP3976803A4 (enExample) |
| JP (2) | JP7755490B2 (enExample) |
| KR (1) | KR20220016071A (enExample) |
| CN (1) | CN113874514A (enExample) |
| AU (1) | AU2020283526A1 (enExample) |
| BR (1) | BR112021024020A2 (enExample) |
| CA (1) | CA3140145A1 (enExample) |
| IL (1) | IL288404B2 (enExample) |
| WO (1) | WO2020242913A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12152281B2 (en) | 2019-05-30 | 2024-11-26 | Trizell Ltd. | Gene therapy vector contamination assay |
| CN111041131B (zh) * | 2020-03-16 | 2020-07-10 | 广东永诺医疗科技有限公司 | 基于微滴式数字pcr的eb病毒检测试剂盒 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6410010B1 (en) * | 1992-10-13 | 2002-06-25 | Board Of Regents, The University Of Texas System | Recombinant P53 adenovirus compositions |
| US6020191A (en) | 1997-04-14 | 2000-02-01 | Genzyme Corporation | Adenoviral vectors capable of facilitating increased persistence of transgene expression |
| WO2001044280A2 (en) | 1999-12-14 | 2001-06-21 | Genovo, Inc. | Methods and compositions for the manufacture of replication incompetent adenovirus |
| EP1513956A2 (en) | 2002-06-07 | 2005-03-16 | Novartis AG | Assay to detect replication competent viruses |
| WO2006060089A2 (en) | 2004-10-25 | 2006-06-08 | Biogen Idec Ma Inc. | Novel methods for producing adenoviral vector preparations with reduced replication-competent adenovirus contamination and novel adenoviral vectors and preparations |
| WO2008079354A2 (en) | 2006-12-22 | 2008-07-03 | Schering Corporation | Methods of detecting replication competent adenovirus |
| CN102884196B (zh) | 2010-04-01 | 2015-05-06 | 肖卫东 | 重组病毒载体的结构及其制备 |
| CA2965074A1 (en) * | 2010-12-27 | 2012-07-05 | Abbott Molecular Inc. | Quantitating high titer samples by digital pcr |
| CN102134613B (zh) * | 2010-12-31 | 2013-01-30 | 中国人民解放军第三军医大学 | 重组慢病毒滴度的检测方法 |
| EP2841064B1 (en) * | 2012-04-26 | 2019-06-12 | Sentient Lifesciences, Inc. | Use of n-acetylcysteine amide in the treatment of cataracts |
| JP2016531561A (ja) | 2013-10-01 | 2016-10-13 | テクセル | 希少な微生物学的核酸の検出 |
| WO2015103367A1 (en) | 2013-12-31 | 2015-07-09 | Raindance Technologies, Inc. | System and method for detection of rna species |
| US11098286B2 (en) | 2015-12-11 | 2021-08-24 | The Trustees Of The University Of Pennsylvania | Scalable purification method for AAV9 |
| ES3054035T3 (en) * | 2016-04-14 | 2026-01-28 | Ferring Ventures Ltd | Fixed-bed bioreactor with constant-flow pump/tubing system |
| GB2549799A (en) * | 2016-04-29 | 2017-11-01 | Nat Univ Ireland Galway | A multiplex assay for the sensitive and specific detection and differentiation of Clostridium difficile |
| WO2018023094A1 (en) | 2016-07-29 | 2018-02-01 | Juno Therapeutics, Inc. | Methods for assessing the presence or absence of replication competent virus |
| CN107794291A (zh) * | 2017-04-10 | 2018-03-13 | 中山大学 | 一种抗新加坡石斑鱼虹彩病毒的药物筛选方法 |
| CN108570449A (zh) * | 2018-05-17 | 2018-09-25 | 石河子大学 | 一种带有自发性kshv裂解复制的神经元细胞的构建方法 |
| US12152281B2 (en) | 2019-05-30 | 2024-11-26 | Trizell Ltd. | Gene therapy vector contamination assay |
-
2019
- 2019-05-30 US US16/426,124 patent/US12152281B2/en active Active
-
2020
- 2020-05-22 KR KR1020217038299A patent/KR20220016071A/ko active Pending
- 2020-05-22 EP EP20812945.2A patent/EP3976803A4/en active Pending
- 2020-05-22 BR BR112021024020A patent/BR112021024020A2/pt unknown
- 2020-05-22 AU AU2020283526A patent/AU2020283526A1/en active Pending
- 2020-05-22 CN CN202080038925.9A patent/CN113874514A/zh active Pending
- 2020-05-22 IL IL288404A patent/IL288404B2/en unknown
- 2020-05-22 JP JP2021569884A patent/JP7755490B2/ja active Active
- 2020-05-22 WO PCT/US2020/034146 patent/WO2020242913A1/en not_active Ceased
- 2020-05-22 CA CA3140145A patent/CA3140145A1/en active Pending
-
2024
- 2024-11-07 US US18/940,233 patent/US20250163519A1/en active Pending
-
2025
- 2025-06-13 JP JP2025099242A patent/JP2025123368A/ja active Pending